All of the aforementioned information supports the conclusion that GAS5 promotes apoptosis, suppresses metastasis, enhances sensitivity to a number of drugs, and increases the survival rate of breast cancer patients, including TNBC, through the participation of some mechanisms according to the ceRNA model (Figure 2). Here, GAS5 is linked to breast cancer.